Gentra Systems Has Been Acquired by Qiagen

Qiagen (NYSE: QGEN), a German molecular diagnostics and sample prep giant, acquired Minneapolis, MN based Gentra Systems, a nucleic acid purification products company, for $38 million. The deal effectively buys out a competitor in a niche where Qiagen had struggled to develop a significant market for its own products.

Tamarack Partners provides M&A advisory services to owners of lower middle market companies. For more information on this transaction or to speak with one of our transactional advisors about your business, Contact Us.